Posts Tagged ‘binge eating disorder’

Disordered Physiology and Disordered Eating

June 23, 2023 — Since January, when the American Academy of Pediatrics released a guideline for treating the disordered physiology of children and youth with obesity, we’ve been inundated with popular psychology influencers concerned about the impact on young persons with disordered eating. Their arguments are quite passionate. “Obesity guidelines for kids terrify me,” says one person with a […]

Can Deep Brain Stimulation Stop Binge Eating?

November 14, 2022 — Two patients. This fits our definition of a small pilot study and Nature Medicine published it recently. In this study, Rajat Shivacharan and colleagues treated binge eating disorder and severe obesity in two patients, using responsive deep brain stimulation. It involves the placement of tiny electrodes in the brain, connected to a pulse generator implanted […]

An Awful Mashup: COVID, Stigma, and Eating Disorders

October 5, 2020 — A new paper from the Rudd Center reminds us how noxious the weight talk in popular media is right now. Rebecca Puhl and colleagues found that weight stigma during the COVID-19 pandemic is toxic. In young adults, past experience of stigma predict problems in coping now. The risk of binge eating triples. Symptoms of depression […]

NEDA, BEDA, and Monica Seles

February 6, 2015 — The first drug treatment ever for binge eating disorder (BED) was just approved by FDA a week ago and already we have NEDA, BEDA, and Monica Seles teaming up with the maker of that drug, Shire plc, on a disease awareness program for BED. Compared to many disease awareness campaigns, this one definitely has merit. Binge […]

First Drug for Binge Eating Disorder May Be Near Approval

January 27, 2015 — The first drug for binge eating disorder may be nearing approval at FDA. Shire’s application for lisdexamfetamine (brand name Vyvanse®) for the treatment of binge eating disorder was accepted at the end of September, which means that the FDA is due to rule on their application by February 1. FDA granted a priority review for […]